IRIS

SPECIALE, ANDREA

SPECIALE, ANDREA  

100022 - Dipartimento di Scienze della terra, dell'ambiente e della vita  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 1-gen-2021 Menichini, P.; Monti, P.; Speciale, A.; Cutrona, G.; Matis, S.; Fais, F.; Taiana, E.; Neri, A.; Bomben, R.; Gentile, M.; Gattei, V.; Ferrarini, M.; Morabito, F.; Fronza, G.
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 1-gen-2020 Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 1-gen-2019 Monteleone, L; Speciale, A; Traverso, N; Garbarino, O; Ravera, S; Domenicotti, C; Marengo, B
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 1-gen-2023 Marengo, B.; Meta, E.; Brullo, C.; Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 1-gen-2018 Marengo, Barbara; Monti, Paola; Miele, Mariangela; Menichini, Paola; Ottaggio, Laura; Foggetti, Giorgia; Pulliero, Alessandra; Izzotti, Alberto; Speciale, Andrea; Garbarino, Ombretta; Traverso, Nicola; Fronza, Gilberto; Domenicotti, Cinzia
Evaluating the influence of a g-quadruplex prone sequence on the transactivation potential by wild-type and/or mutant p53 family proteins through a yeast-based functional assay 1-gen-2021 Monti, P.; Brazda, V.; Bohalova, N.; Porubiakova, O.; Menichini, P.; Speciale, A.; Bocciardi, R.; Inga, A.; Fronza, G.
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 1-gen-2017 Domenicotti, CINZIA MARIA; Speciale, Andrea; Garbarino, Ombretta; Izzotti, Alberto; Fenoglio, Daniela; Ravera, Silvia; Pulliero, Alessandra; Passalacqua, Mario; Traverso, Nicola; Pronzato, MARIA ADELAIDE; Marengo, Barbara
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 1-gen-2016 Colla, Renata; Izzotti, Alberto; De Ciucis, Chiara; Fenoglio, Daniela; Ravera, Silvia; Speciale, Andrea; Ricciarelli, Roberta; Furfaro, Annalisa; Pulliero, Alessandra; Passalacqua, Mario; Traverso, Nicola; Pronzato, Maria Adelaide; Domenicotti, Cinzia; Marengo, Barbara
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 1-gen-2020 Monti, P.; Menichini, P.; Speciale, A.; Cutrona, G.; Fais, F.; Taiana, E.; Neri, A.; Bomben, R.; Gentile, M.; Gattei, V.; Ferrarini, M.; Morabito, F.; Fronza, G.
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809 1-gen-2017 Marengo, Barbara; Speciale, Andrea; Senatore, Lisa; Garibaldi, Silvano; Musumeci, Francesca; Nieddu, Erika; Pollarolo, Benedetta; Pronzato, MARIA ADELAIDE; Schenone, Silvia; Mazzei, Mauro; Domenicotti, CINZIA MARIA
MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome 1-gen-2020 Speciale, Andrea; Monti, Paola; Fronza, Gilberto; Izzotti, Alberto; Menichini, Paola
Mutant p53K120R expression enables a partial capacity to modulate metabolism 1-gen-2022 Monti, Paola; Ravera, Silvia; Speciale, Andrea; Velkova, Irena; Foggetti, Giorgia; Degan, Paolo; Fronza, Gilberto; Menichini, Paola
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 1-gen-2019 Marengo, Barbara; Garbarino, Ombretta; Speciale, Andrea; Monteleone, Lorenzo; Traverso, Nicola; Domenicotti, Cinzia
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 1-gen-2021 Monteleone, L.; Speciale, A.; Valenti, G. E.; Traverso, N.; Ravera, S.; Garbarino, O.; Leardi, R.; Farinini, E.; Roveri, A.; Ursini, F.; Cantoni, C.; Pronzato, M. A.; Marinari, U. M.; Marengo, B.; Domenicotti, C.
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma 1-gen-2021 Marengo, Barbara; Pulliero, Alessandra; Corrias, Maria Valeria; Leardi, Riccardo; Farinini, Emanuele; Fronza, Gilberto; Menichini, Paola; Monti, Paola; Monteleone, Lorenzo; Valenti, Giulia Elda; Speciale, Andrea; Perri, Patrizia; Madia, Francesca; Izzotti, Alberto; Domenicotti, Cinzia
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 1-gen-2018 Speciale, Andrea; Marengo, Barbara; Traverso, Nicola; Cantoni, Claudia; Ravera, Silvia; Garbarino, Ombretta; Pronzato, Maria Adelaide; Domenicotti, Cinzia
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. 1-gen-2018 Speciale, A; Marengo, B; Traverso, N; Monteleone, L; Cantoni, C; Ravera, S; Garbarino, O; Pronzato, Ma; Domenicotti, C.
“The Blinded Guardian”: clinical relevance of p53-null phenotype in high-grade serous ovarian cancers 1-gen-2021 Parrella, V; Biatta, Cm; Paudice, M; Damiano, G; De Luca, G; Speciale, A; Cerruti, G; Mammoliti, S; Menichini, P; Vellone, Vg